September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...
September 6, 2019 — Business-to-business communications company Scranton Gillette Communications has named Diane ...
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...
September 4, 2019 – Novartis announced results from two new clinical trials evaluating improvement in heart structure ...
September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven ...
September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
August 28, 2019 — AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of ...
A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve ...
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the ...
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...
September 11, 2019